Treatment with mesenchymal stem cells reverses fibrotic signaling via exosomal mRNA cargo
Cellula staminale mesenchimale (MSC) therapy shows promise in reversing fibrosis. New research reveals MSC-derived exosomes deliver mRNA cargo, actively suppressing fibrotic signaling pathways. This mechanism offers a novel therapeutic target for fibrotic diseases. Saperne di più.










